182 products listed in NHI reimbursement from Dec.

Published: 2003-11-04 06:59:00

Updated: 2003-11-04 06:59:00

In the 9th health insurance policy review meeting on Oct. 31 the MOHW approved 182 new products to be listed in the NHI reimbursement schedule and the upper limited prices for 8 non-NHI reimbursable drugs as well.

182 new products included 3 new brand products and 3 with new ingredients, and o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK